Discover how the Novavax COVID-19 vaccine offers a protein-based alternative with fewer side effects compared to mRNA vaccines, based on recent studies.
All posts tagged: Vaccines
ASSURE In the News
Next-Gen COVID-19 Vaccines by INOVIO, Ocugen, Pfizer in 2025
Explore the latest COVID-19 vaccines in development by INOVIO, Ocugen, and Pfizer. Learn about new delivery platforms and what’s next in SARS-CoV-2 protection.
Anti-Vaccine Sentiment Threatens Future FDA Vaccine Approvals
Concerns rise as anti-vaccine views in government threaten the approval process for new vaccines awaiting FDA and regulatory review in 2025.
Novavax Delay & RFK Jr.’s Vaccine Misinformation in 2025
Explore the latest on the Novavax COVID-19 vaccine delay and RFK Jr.’s false claims about vaccine safety, with facts from experts and public health agencies.
US COVID-19 Management Updates and Best Practices for April 2025
Stay informed about the latest US government COVID-19 policies, vaccination guidelines, and best practices as of April 2025 to protect yourself and others.
Latest COVID-19 Booster Shot: Updates and Eligibility
Learn about the updated 2024–2025 COVID-19 booster shots, including vaccine options, eligibility criteria, and availability as of March 2025.
COVID-19 Transmission Post-Vaccination and Latest Booster Updates
Explore the potential for COVID-19 transmission after vaccination and learn about the latest booster updates as of March 2025.
Updated COVID-19 Vaccines and Boosters: March 2025
Learn about the latest COVID-19 vaccine updates and booster recommendations as of March 2025, including availability and guidelines for different age groups.
HHS and Secretary Robert F. Kennedy Jr.’s 2025 Actions on COVID-19 Vaccines
Explore the recent initiatives and statements by HHS and Secretary Robert F. Kennedy Jr. concerning COVID-19 vaccines in 2025, including policy changes and public health implications.
Pfizer & BioNTech vs. Moderna: COVID-19 Vaccine Patent Lawsuit
Get the latest updates on the ongoing legal battle between Pfizer, BioNTech, and Moderna over COVID-19 vaccine patents in 2025. Learn what’s at stake.